Drug Shortage Report for BRIMONIDINE P
Report ID | 202748 |
Drug Identification Number | 02301334 |
Brand name | BRIMONIDINE P |
Common or Proper name | Brimonidine P |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | BRIMONIDINE TARTRATE |
Strength(s) | 0.15% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 10ML |
ATC code | S01EA |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-08-24 |
Actual start date | |
Estimated end date | 2023-10-13 |
Actual end date | 2023-10-13 |
Shortage status | Resolved |
Updated date | 2023-10-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2023-10-14 | English | Compare |
v11 | 2023-10-13 | French | Compare |
v10 | 2023-10-13 | English | Compare |
v9 | 2023-10-12 | French | Compare |
v8 | 2023-10-12 | English | Compare |
v7 | 2023-09-27 | French | Compare |
v6 | 2023-09-27 | English | Compare |
v5 | 2023-08-30 | French | Compare |
v4 | 2023-08-30 | English | Compare |
v3 | 2023-08-25 | English | Compare |
v2 | 2023-08-23 | French | Compare |
v1 | 2023-08-23 | English | Compare |
Showing 1 to 12 of 12